End-of-day quote
Ljubljana S.E.
06:00:00 2024-04-24 pm EDT
|
5-day change
|
1st Jan Change
|
1,990
EUR
|
-2.45%
|
|
-.--%
|
+10.56%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
60.55
|
72.02
|
93.94
|
148.2
|
145.1
|
189.7
|
Enterprise Value (EV)
1 |
60.68
|
72.77
|
98.21
|
143
|
142
|
189.1
|
P/E ratio
|
14.1
x
|
12.2
x
|
9.27
x
|
11.4
x
|
11.1
x
|
18.4
x
|
Yield
|
6.17%
|
6.52%
|
6.11%
|
4.58%
|
5.04%
|
3.89%
|
Capitalization / Revenue
|
0.24
x
|
0.21
x
|
0.23
x
|
0.32
x
|
0.29
x
|
0.32
x
|
EV / Revenue
|
0.24
x
|
0.21
x
|
0.25
x
|
0.31
x
|
0.29
x
|
0.32
x
|
EV / EBITDA
|
8.93
x
|
6.88
x
|
6.96
x
|
8.06
x
|
8.81
x
|
11.3
x
|
EV / FCF
|
-8.18
x
|
18.2
x
|
-87.4
x
|
10.7
x
|
21.7
x
|
17.4
x
|
FCF Yield
|
-12.2%
|
5.48%
|
-1.14%
|
9.35%
|
4.6%
|
5.75%
|
Price to Book
|
1.2
x
|
1.32
x
|
1.56
x
|
2.2
x
|
1.96
x
|
2.45
x
|
Nbr of stocks (in thousands)
|
101
|
104
|
104
|
104
|
104
|
105
|
Reference price
2 |
600.0
|
690.0
|
900.0
|
1,420
|
1,390
|
1,800
|
Announcement Date
|
4/25/19
|
3/16/20
|
3/15/21
|
3/4/22
|
3/13/23
|
2/28/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
253.2
|
348
|
400.7
|
458.3
|
495.7
|
599.4
|
EBITDA
1 |
6.793
|
10.58
|
14.12
|
17.76
|
16.12
|
16.71
|
EBIT
1 |
4.747
|
7.825
|
11.65
|
14.99
|
13.24
|
13.26
|
Operating Margin
|
1.88%
|
2.25%
|
2.91%
|
3.27%
|
2.67%
|
2.21%
|
Earnings before Tax (EBT)
1 |
5.348
|
7.474
|
12.6
|
16.37
|
16.41
|
13.09
|
Net income
1 |
4.291
|
5.903
|
10.13
|
13.01
|
13.1
|
10.27
|
Net margin
|
1.69%
|
1.7%
|
2.53%
|
2.84%
|
2.64%
|
1.71%
|
EPS
2 |
42.54
|
56.55
|
97.06
|
124.6
|
125.5
|
97.86
|
Free Cash Flow
1 |
-7.418
|
3.988
|
-1.123
|
13.37
|
6.538
|
10.86
|
FCF margin
|
-2.93%
|
1.15%
|
-0.28%
|
2.92%
|
1.32%
|
1.81%
|
FCF Conversion (EBITDA)
|
-
|
37.69%
|
-
|
75.31%
|
40.56%
|
65%
|
FCF Conversion (Net income)
|
-
|
67.56%
|
-
|
102.81%
|
49.93%
|
105.78%
|
Dividend per Share
2 |
37.00
|
45.00
|
55.00
|
65.00
|
70.00
|
70.00
|
Announcement Date
|
4/25/19
|
3/16/20
|
3/15/21
|
3/4/22
|
3/13/23
|
2/28/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
0.13
|
0.76
|
4.27
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
5.17
|
3.06
|
0.59
|
Leverage (Debt/EBITDA)
|
0.0197
x
|
0.0714
x
|
0.3026
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
-7.42
|
3.99
|
-1.12
|
13.4
|
6.54
|
10.9
|
ROE (net income / shareholders' equity)
|
8.56%
|
11.2%
|
17.7%
|
20.4%
|
18.6%
|
13.6%
|
ROA (Net income/ Total Assets)
|
2.67%
|
3.71%
|
5.15%
|
5.94%
|
4.82%
|
4.25%
|
Assets
1 |
160.5
|
158.9
|
196.6
|
218.9
|
271.9
|
242
|
Book Value Per Share
2 |
499.0
|
523.0
|
575.0
|
645.0
|
708.0
|
736.0
|
Cash Flow per Share
2 |
131.0
|
137.0
|
84.50
|
169.0
|
183.0
|
215.0
|
Capex
1 |
0.39
|
1.21
|
3.25
|
4.05
|
2.25
|
5.72
|
Capex / Sales
|
0.15%
|
0.35%
|
0.81%
|
0.88%
|
0.45%
|
0.95%
|
Announcement Date
|
4/25/19
|
3/16/20
|
3/15/21
|
3/4/22
|
3/13/23
|
2/28/24
|
|
1st Jan change
|
Capi.
|
---|
| +10.56% | 226M | | -10.75% | 8.88B | | +39.05% | 1.43B | | +8.27% | 438M | | -2.22% | 268M | | -8.26% | 86.33M | | -46.43% | 82.6M | | +23.75% | 62.75M |
Retail - Drugs without Grocery
|